Hans-Peter Hofmann | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Hans-Peter Hofmann is active.

Explore More

Publication

Featured researches published by Hans-Peter Hofmann.

Journal of Medicinal Chemistry | 2003

Benzoylalanine-Derived Ketoamides Carrying Vinylbenzyl Amino Residues: Discovery of Potent Water-Soluble Calpain Inhibitors with Oral Bioavailability

Wilfried Lubisch; Edith Beckenbach; Sabina Bopp; Hans-Peter Hofmann; Arzu Kartal; Claudia Kästel; Tanja Lindner; Marion Metz-Garrecht; Jutta Reeb; Ferdinand Regner; Michael Vierling; Achim Möller

Archive | 1999

Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia

Gerd Steiner; Kurt Schellhaas; Wilfried Lubisch; Uta Holzenkamp; Dorothea Starck; Monika Knopp; Laszlo Szabo; Franz Emling; Francisco Javier Garcia-Ladona; Hans-Peter Hofmann; Liliane Unger

Archive | 1997

Pyrrolyl quinoxalindiones their production and use as AMPA receptor antagonists

Wilfried Lubisch; Berthold Behl; Hans-Peter Hofmann; Laszlo Szabo

Archive | 2000

Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances

Francisco Javier Garcia-Ladona; Laszlo Szabo; Gerd Steiner; Hans-Peter Hofmann

Archive | 2004

Use of binding partners for 5-HT5 receptors for the treatment of neurodegenerative and neuropsychiatric disorders

Francisco Javier Garcia-Ladona; Laszlo Szabo; Gerd Steiner; Hans-Peter Hofmann

Archive | 2002

Utilisation of 2-substituted 1,2-benzisothiazole derivatives and 3-substituted tetrahydropyridopyrimidinone derivatives for the prophylaxis and therapy of cerebral ischaemia

Gerd Steiner; Kurt Schellhaas; Wilfried Lubisch; Uta Holzenkamp; Dorothea Starck; Laszlo Szabo; Franz Emling; Francisco Javier Garcia-Ladona; Hans-Peter Hofmann; Liliane Unger

Archive | 1999

Verwendung von 2-substituierten 1,2-benzisothiazol-derivaten und von 3-substituierten tetrahydropyridopyrimidinon-derivaten zur prophylaxe und therapie der zerebralen ischämie

Gerd Steiner; Kurt Schellhaas; Wilfried Lubisch; Uta Holzenkamp; Dorothea Starck; Laszlo Szabo; Franz Emling; Francisco Javier Garcia-Ladona; Hans-Peter Hofmann; Liliane Unger

Archive | 1999

Verwendung von Bindungspartnern für 5-HT5-Rezeptoren zur Behandlung neurodegenerativer und neuropsychiatrischer Störungen Use of binding partners for 5-HT5 receptors for the treatment of neurodegenerative and neuropsychiatric disorders

Francisco Javi Garcia-Ladona; Laszlo Szabo; Gerd Steiner; Hans-Peter Hofmann

Archive | 1999

Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie Use of compounds of formula I for the prophylaxis and therapy of cerebral ischemia

Gerd Steiner; Kurt Schellhaas; Wilfried Lubisch; Uta Holzenkamp; Dorothea Starck; Laszlo Szabo; Franz Emling; Francisco Javi Garcia-Ladona; Hans-Peter Hofmann; Liliane Unger

Archive | 1997